FORMES POSOLOGIQUES ORALES PHARMACEUTIQUES POUR LE TRAITEMENT DES TROUBLES MÉTABOLIQUES ET DES MALADIES CONNEXES PAR LA LIBÉRATION ORCHESTRÉE D'ENTÉROKINASES
The present invention relates to pharmaceutical oral dosage forms releasing compounds in specific parts of the small intestine of a subject, wherein said compounds stimulate enteroendocrine cells in the subject's jejunum and lower small intestine to release one or more enterokines. The present invention also relates to a method of producing such pharmaceutical oral dosage forms. The pharmaceutical oral dosage forms of the invention are particularly for use in the treatment and prevention of metabolic conditions or diseases, osteoporosis, malabsorption conditions, neurodegenerative diseases, conditions of impaired gastro-intestinal function and cardiovascular diseases.